Oral Sodium Chloride Dosing for Pediatric Hyponatremia
For pediatric patients with hyponatremia requiring oral sodium supplementation, use 1-2 grams of sodium chloride per day divided into multiple doses, with the specific dose individualized based on the patient's age, weight, severity of hyponatremia, and underlying etiology.
Dosing Framework
FDA-Approved Oral Sodium Chloride Solution (23.4%)
The concentrated oral sodium chloride solution provides 4 mEq/mL of sodium 1:
- Ages 9-50 years: 4 mL (equivalent to 936 mg sodium chloride, providing 368 mg elemental sodium)
- Children under 9 years: Requires physician consultation for individualized dosing 1
Evidence-Based Dosing Strategies
For prevention of hyponatremia (e.g., in children on oxcarbazepine):
- 1-2 grams of oral sodium chloride daily for 12 weeks has been shown to significantly reduce the incidence of hyponatremia (4/60 vs 14/60 patients, p=0.01) 2
- This regimen increased mean serum sodium levels by approximately 1 mEq/L compared to controls (136.5 vs 135.4 mEq/L) 2
For acute symptomatic hyponatremia:
- Hourly oral sodium chloride tablets calculated to deliver the equivalent of 0.5 mL/kg/hour of 3% NaCl can provide graded, predictable correction 3
- Target correction rate: approximately 6 mEq/L over the treatment period 3
- This approach requires intensive monitoring but can be effective when IV access or ICU transfer is not feasible 3
Clinical Context and Etiology-Specific Considerations
Cerebral Salt Wasting (CSW)
For children with CNS injury (trauma, seizures, hydrocephalus) presenting with hyponatremia, high urine sodium, and hypovolemia:
- Volume-for-volume urine replacement with 0.9% or 3% sodium chloride IV initially 4
- Transition to oral salt supplementation for maintenance after stabilization 4
- This differs critically from SIADH, where fluid restriction is primary therapy
SIADH and Euvolemic Hyponatremia
- First-line: Fluid restriction (500 mL/day initially, adjusted based on response) 5
- Second-line options when fluid restriction fails (approximately 50% of cases): oral urea or vaptans 5
- Oral sodium supplementation alone is generally insufficient for SIADH
Hypervolemic Hyponatremia (e.g., pneumonia with volume overload)
- 0.9% sodium chloride IV plus furosemide is effective for severe cases 6
- Oral sodium supplementation is not appropriate in hypervolemic states
Critical Safety Parameters
Correction Rate Limits
Never exceed 10-12 mEq/L sodium correction per 24 hours (≤8 mEq/L in high-risk patients) to prevent osmotic demyelination syndrome 5, 7:
High-risk features requiring slower correction (≤8 mEq/L/24h):
- Severe hyponatremia (≤105 mmol/L)
- Alcoholism or malnutrition
- Liver disease
- Concurrent hypokalemia 7
Monitoring Requirements
- Frequent serum sodium checks (every 2-4 hours initially for acute symptomatic cases) 3
- Be prepared to administer hypotonic fluids or desmopressin if overcorrection occurs 5
- Monitor for symptoms: headache, confusion, lethargy, seizures (can be nonspecific in children) 8
Important Caveats
This guidance does NOT apply to 8:
- Neonates <28 days old
- Neurosurgical patients
- Congenital/acquired cardiac disease
- Hepatic disease, cancer, renal dysfunction
- Diabetes insipidus
- Severe burns or voluminous diarrhea
Contraindications to oral therapy:
- Altered mental status
- Inability to tolerate oral/NG intake
- Ileus or anatomical GI abnormalities 9
Practical Algorithm
- Assess volume status (hypo-, eu-, or hypervolemic) and identify underlying cause
- For hypovolemic hyponatremia: IV isotonic saline is preferred over oral supplementation 7
- For euvolemic hyponatremia with mild symptoms: Start fluid restriction; add oral sodium chloride 1-2 g/day if inadequate response 2, 5
- For acute symptomatic hyponatremia: Consider hourly oral NaCl (0.5 mL/kg/h equivalent of 3% NaCl) only if IV therapy unavailable 3
- Monitor sodium every 4-6 hours and adjust therapy to stay within safe correction limits
- For prevention (e.g., oxcarbazepine therapy): 1-2 g/day divided doses 2
The key distinction is that oral sodium chloride is most appropriate for prevention or mild chronic hyponatremia in euvolemic states, while acute symptomatic cases typically require IV therapy with isotonic or hypertonic saline for safety and predictability.